Research Square reposted this
Treatment with tixagevimab/cilgavimab (#Evusheld®)—a monoclonal antibody combination injectable therapy—has demonstrated effectiveness in patients with hematologic disorders, including paroxysmal nocturnal hemoglobinuria, according to findings from a single-center study published as a preprint in Research Square. Read more: https://brnw.ch/21wGRor #RareDisease #Hematology